triazoles has been researched along with sphingosine 1-phosphate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, Y; Goitsuka, R; Harima, N; Hidano, S; Hirayama, T; Igarashi, Y; Inoue, T; Matsumoto, K; Nakazawa, K; Ohtake, H; Ono, N; Sakurai, T; Takayama, T; Tsukahara, N | 1 |
Fujii, Y; Fukasawa, Y; Goitsuka, R; Hara, T; Hirayama, T; Igarashi, Y; Ohtake, H; Ono, N; Sakurai, T; Shiozawa, F; Takahashi, S; Takayama, T; Tsukahara, N | 1 |
Fujii, Y; Goitsuka, R; Igarashi, Y; Nakazawa, K; Ohtake, H; Ono, N; Takayama, T; Ueda, Y | 1 |
Abegg, D; Adibekian, A; Childs-Disney, JL; Costales, MG; Disney, MD; Hoch, DG; Velagapudi, SP | 1 |
4 other study(ies) available for triazoles and sphingosine 1-phosphate
Article | Year |
---|---|
Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities.
Topics: Animals; Arthritis, Experimental; B-Lymphocytes; Cricetinae; Cricetulus; HEK293 Cells; Humans; Immune Tolerance; Immunosuppressive Agents; Lymphopenia; Lysophospholipids; Male; Mice; Sphingosine; Sulfones; T-Lymphocytes; Thymus Gland; Triazoles | 2012 |
Lymphopenia induced by a novel selective S1P(1) antagonist structurally unrelated to S1P.
Topics: Animals; Chemotaxis; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dermatitis, Contact; Ear; Edema; Female; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Hyperplasia; Leukocytes; Lymphopenia; Lysophospholipids; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Protein Binding; Rats; Rats, Inbred Lew; Receptors, Lysosphingolipid; Sphingosine; Sulfonamides; Triazoles | 2012 |
Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis.
Topics: Cell Line, Tumor; Human Umbilical Vein Endothelial Cells; Humans; Lysophospholipids; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Sulfones; Triazoles; Vascular Endothelial Growth Factor A | 2012 |
A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents; Base Sequence; Benzimidazoles; Cell Line, Tumor; Drug Design; Humans; Lysophospholipids; MicroRNAs; Phosphotransferases (Alcohol Group Acceptor); Proteome; Receptor, ErbB-2; RNA Precursors; Sphingosine; Trastuzumab; Triazoles | 2019 |